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Abstract  
Background: Anxiety and depression disorders are common in palliative care. The impact of these 
disorders on quality of life and on existential concerns is strong. This research was performed to assess 
the prevalence of anxiety and depression in patients with advanced gynecological cancer. 
Materials and Methods: We conducted a prospective study over a period of 2 years in 98 patients with 
advanced gynecological cancer. The 98 patients included in the study were divided into two categories 
by age (under 55 years and over 56 years). The patients were evaluated at first admission (Basic visit) 
and after 3 months (Follow up visit), by means of 1 questionnaire: Hospital Anxiety and Depression 
Scale – HADS. 
Results: The percentage of women who experience abnormal level of anxiety is: 13,73% for the first 
category of age (under 55years) and 12,77% for the second category of age (over 56 years) at Basic 
visit, while, at Follow up visit, the percentage is 15,69% for the first category of age and 19,15% for 
the second category of age. The percentage of women who do experience abnormal level of depression 
at Basic visit is 11,76% for the first category of age and 12,77% for the second category of age, while, 
at Follow up visit, the percentage is 9,50% for the first category of age and 25,53% for the second 
category of age. There is a statistical difference between Basic visit and Follow up visit in patients from 
the second category of age, the percentage of women who experience abnormal level of depression is 
increasing from 12,77% to 25,53%. 
Discussions and Conclusions: Anxiety and depression are reported to impact significantly on quality 
of life of palliative care patients with advanced gynaecological cancer.  In conclusion, continuous 
screening for anxiety and depression is recommended as a necessary approach for patients with 
advanced gynaecological cancer. 
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1. Introduction 
Cervical cancer is the third most prevalent cancer (9%) worldwide, and the fourth cause of 
cancer mortalities (8%) in women (Small et al., 2017). This cancer is a risk factor for developing 
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depression in women, having a negative impact to their quality of life or to their compliance 
with the treatments. Ovarian cancer is the eighth most commonly occurring cancer in women.  
Women with advanced ovarian cancer are at persistent risk of anxiety and reactive depression 
due to poor prognosis and risk of burdensome symptoms (Mielcarek et al., 2016).  
In a study evaluating psychological distress in patients with ovarian cancer, Bodurka et al. 
identified that depression and anxiety rates were 21% and 29% (Bodurka-Bevers et al., 2000). 
Depression affects up to 20%, and anxiety 10% of patients with cancer (Pitman et al., 2018). 
These two symptoms are often assessed together (Brintzenhofe-Szoc et al., 2009). Anxiety often 
precedes depression. Anxiety and depression disorders are common in palliative care. The 
impact of these disorders on quality of life and on existential concerns is strong (Settineri et al., 
2012; Martino et al., 2018a, 2018b; Catalano et al., 2018). 
Different medical conditions are characterized by experiences and psychological aspects whose 
relevance affects the general dynamics of self-adaptation and representation (Marchini et al., 
2018). This emerges as a sense of relevant loss, which is central to the psychological and 
psychopathological consideration of patients. 
There is an association between anxiety and depression and physical symptoms (pain, fatigue, 
weight loss) (Mazilu et al., 2019; Ciocirlan et al., 2017; Ciuhu et al., 2017). Also, these disorders 
can make the management of physical symptoms (Wilson et al., 2007; Rahnea et al., 2016; 
Settineri et al., 2018) and adherence to therapies more difficult (Settineri et al., 2019).  
Anxiety and depression are under detected and undertreated in palliative care patients with 
advanced cancer;  
this symptoms create unnecessary suffering (Nitipir et al., 2018). About 15% of palliative care 
patients meet criteria for major depressive disorder and many more experience depressive 
symptoms (Hotopf et al., 2002).  
Anxiety disorders have been studied less extensively than depression and is not only associated 
in the oncology pathology, but is also common in other pathologies such as diabetes or post-
gastric-sleeve (Timofte et al., 2018a; Timofte et al., 2018b; Zugravu et al., 2012; Stark et al., 
2002).  
This research was performed to assess the prevalence of the anxiety and depression in patients 
with advanced gynecological cancer. 
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2. Materials and Methods 
We conducted a prospective study in patients with advanced gynecological cancer admitted to 
“Prof. Dr. Alexandru Trestioreanu” Oncological Institute and “Saint Luca” Hospital of chronic 
diseases – Oncology – Palliative Care Department. 
A number of 98 female patients were included in the study. The 98 patients included in the 
study were divided into two categories, by age (under 55 years and over 56 years). 
The patients were evaluated at first admission (Basic visit) and after 3 months (Follow up visit), 
by means of 1 questionnaire: Hospital Anxiety and Depression Scale – HADS (Appendix 1) 
(Zigmond & Snaith, 1983). 
HADS is free and available online. It is a self-report measurement tool designed for assessment 
depression and anxiety.  Responses provided separate scores for anxiety and depression (each 
of anxiety or depression scale has a score range of 0-21. Total score is: 0-7 = Normal, 8-10 = 
Borderline, 11-21 = Abnormal). 
The questionnaire was completed by the patients during their admission in the hospital or by 
telephone interview. 
The approval from the Ethical Commission has been previously obtained. The patients were 
explained about the purpose and importance of the study and they freely agreed to participate 
in the study by signing the informed consent. 
 
3. Results 
Fig 1. Patients distribution according to the diagnostic (cervical, ovarian, endometrial) 
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Fig 2. Patients distribution according to the life environment (urban, rural) 
 
Fig 3. Patient’s distribution according to the studies (elementary, high school, university) 
 
Fig 4. Patient’s distribution according to the age category (under 55 years, over 56 years)  
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Fig 5. HADS- Basic visit-first age category (under 55 years) (anxiety: normal, borderline, 
abnormal; depression: normal, borderline, abnormal)  
 
Fig 6. HADS Basic visit - second age category (over 56 years) (anxiety: normal, borderline, 
abnormal; depression: normal, borderline, abnormal) 
 
Fig 7. HADS - Follow up visit - first age category (under 55 years) (anxiety: normal, borderline, 
abnormal; depression: normal, borderline, abnormal) 
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Fig 8. HADS Follow up visit - second age category (over 56 years) (anxiety: normal, borderline, 
abnormal; depression: normal, borderline, abnormal) 
 
 
4. Discussions 
Anxiety and depression have physical and psychological symptoms (Settineri et al., 2019). They 
are associated with impaired physical, social, and family functioning (Jones, 2001). Patients with 
anxiety experience tension, insomnia, hyperactivity, breathlessness and numbness. The severity 
of symptoms can include generalized anxiety, panic disorder and social anxiety. 
Patients with depression experience hopelessness, guilt and also, suicidal thoughts. Other 
symptoms of depression are fatigue and loss of energy,  decreased ability to concentrate, 
difficulty making decisions and memory problems. Risk factors for anxiety and depression are: 
mental disorders, severe physical symptoms, poor relationships and communication between 
medical team and patient, history of mood disorder or alcohol or drugs abuse, personality 
disorders and social difficulties. 
Depression and anxiety do not represent the understandable reactions to incurable illness. It is 
an error of approach them in this way because the lack of diagnostic of this symptoms can result 
in an undertreatment of a psychiatric disorder (Barraclough, 1997). Cancer can cause uncertainty 
regarding diagnostic, prognostic, and also fears about dying and death. Physical symptoms such 
as pain and nausea, loss of functional capacity, loss of independence can influence negatively 
the life of the patient. Practical issues such as work, finance can appear. 
In patients with gynaecological cancers, changes in body image, sexual dysfunction, infertility 
affect dramatically their quality of life (Hutter et al., 2013). Depression and anxiety frequently 
occur in oncology patients and have an important impact even regarding the disease outcome 
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(Jones, 2001). This two symptoms have to be regarded as indicators of quality of life rather than 
determinants (Hutter et al., 2013). 
Diagnosis of depression and anxiety may be facilitated by using screening tools (Jones, 2001). 
HADS focuses on non-physical symptoms, it is easy for use. The HADS questionnaire has been 
validated in many languages and countries. This measure was intended to be used by hospital 
staff to determine if patients (outpatients, inpatients) are experiencing psychological distress. 
The scale has fourteen items, seven of them measure depression and seven of them measure 
anxiety. Scores on the scale are intended to provide a method of determining patients’ 
psychological distress in terms of these two common emotional disorders. HADS contribute to 
the selection of patients with psychologically distress. 
It is important to recognize anxiety and depression, because poor recognition of this symptoms 
is associated with low quality of life and also, survival. Clinicians should assess and monitor 
patients for both anxiety and depression on a regular basis. Some patients with anxiety may 
require intervention and some may not. Addressing their concerns directly, and controlling 
symptoms is enough for some of them. For patients with depression it is important to determine 
whether to use pharmacotherapy for depressive symptoms or to explore the concerns of the 
patient. Patients with elevated level of this two symptoms may benefit from treatment and from 
more intensive monitoring. Management for gynecological cancer patients should include a 
screening questionnaire for psychological distress, and, for those whose screening indicates 
depressive and anxiety symptomatology, referral to a specialist for further evaluation. Coping 
strategies are very important in patients quality of life and their psychosocial adaptation to 
cancer. Psycho-oncology support programs are needed to help patients using coping strategies 
to improve overall quality of life (Tarik, 2014). 
We analyzed the results obtained from the questionnaire Hospital Anxiety and Depression Scale.  
Regarding anxiety: The percentage of women who experience abnormal level of anxiety is: at 
Basic visit- 13,73% for the first category of age and 12,77% for the second category of age, 
while, at Follow up visit, the percentage are 15,69% for the first category of age and 19,15% for 
the second category of age. Regarding the level borderline, at Basic visit, the percentage is: 
33,33% of patients for the first category of age and 38,30% for the second category of age. At 
Follow up visit, the percentage is 29,41% for the first category of age and 27,66% for the second 
category of age. Regarding the level normal, the percentage of patients, at Basic visit is: 52,94% 
of patients for the first category of age and 48,94% for the second category of age. At Follow 
up visit, the percentage is 54,90% for the first category of age and 53,19% for the second 
category of age. 
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Regarding depression: The percentage of women who do experience abnormal level of 
depression at Basic visit - 11,76% for the first category of age and 12,77% for the second 
category of age, while, at Follow up visit, the percentage is 9,50% for the first category of age 
and 25,53% for the second category of age. There is a statistical difference between Basic visit 
and Follow up visit in patients from the second category of age, the percentage of women who 
experience abnormal level of depression is increasing from 12,77% to 25,53%. 
Regarding the level borderline, the percentage of patients at Basic visit, is: 29,41% of patients 
for the first category of age and 31,91% for the second category of age. At Follow up visit, the 
percentage is 33,33% for the first category of age and 27,66% for the second category of age. 
Regarding the level normal, the percentage of patients at Basic visit, is: 58,82% of patients for 
the first category of age and 63,83% for the second category of age. At Follow up visit, the 
percentage is 56,86% for the first category of age and 46,81% for the second category of age. 
There is a statistical difference between Basic visit and Follow up visit in patients from the 
second category of age, the level normal is decreasing from 63,83% to 46,81%. 
 
5. Conclusions 
Hospital anxiety and depression scale (HADS), developed by Zigmond and Snaith in 1983 is a 
useful instrument for detecting and screening depression and anxiety in clinical settings (Balescu 
et al., 2018; Nikbakhsh et al., 2014). In terms of Anxiety, the level of this symptom is high, both 
age category have abnormal and borderline anxiety, at Basic visit and at Follow up visit. In terms 
of Depression, the level of this symptom is, also, high. There is a statistical difference between 
Basic visit and Follow up visit in patients from the second category of age, the level abnormal 
is increasing from 12,77% to 25,53%. Anxiety and depression are reported to impact 
significantly on quality of life of palliative care patients with advanced gynecological cancer 
(Balescu et al., 2018). In conclusion, continuous screening for anxiety and depression is 
recommended as a necessary approach for patients with advanced gynecological cancer (Badiu 
et al., 2018; Paduraru et al., 2018). 
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